Health Care/Hospital Global News & Press Release Distribution

Health Care/Hospital

All
APAC

Mandatory Certification for MoCA Cognitive Assessment Now Free for Students, Faculty and Academic Researchers

MoCA—the most sensitive test available for detecting the earliest stages of Alzheimer's and other cognitive disorders—now offers free certification training for academia. MONTREAL, Oct. 20, 2021 /PRNewswire/ -- MoCA's official one-hour online training and certification module is now available a...

2021-10-20 01:09 2564

Mandatory Certification for MoCA Cognitive Assessment Now Free for Students, Faculty and Academic Researchers

E-Home Household Service Holdings Limited Dissolves the VIE Structure

FUZHOU, China, Oct. 19, 2021 /PRNewswire/ -- E-Home Household Service Holdings Limited (Nasdaq: EJH) (the "Company" or "E-Home"), a provider of integrated household services inChina, today announced that its indirectly wholly owned Chinese subsidiary, E-Home Household Service Technology Co., Ltd....

2021-10-19 20:30 3143

PharmAbcine Announces Patent Grant in Australia for Its Anti-VISTA Antibody

DAEJEON, South Korea, Oct. 19, 2021 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of next-generation antibody therapeutics, announced today that the patent for PMC-309, one of the Company's first immuno-oncology assets, has been ...

2021-10-19 20:00 1373

Harbour BioMed Announces Dosing of First Patient of Batoclimab Phase II Trial in Patients with Thyroid Eye Disease

CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and SUZHOU, China, Oct. 19, 2021 /PRNewswire/ -- Harbour BioMed ("HBM", HKEX: 02142) announced that, the clinical trial of its anti-FcRn antibody, batoclimab (HBM9161), has completed the first dosing of first patient in phase II trial for the treatment ...

2021-10-19 17:52 1803

FDA Pre-Submission for Saliva-Based Glucose Test to Replace Invasive Finger-Prick

SYDNEY, Oct. 19, 2021 /PRNewswire/ -- The iQ Group Global Ltd (NSX.IQG), on behalf of its subsidiary, Life Science Biosensor Diagnostics Pty Ltd (LSBD), is pleased to announce that one of its licensees, GBS Inc (Nasdaq: GBS); a life sciences company operating in theAsia Pacific region, under lice...

2021-10-19 15:01 1666

InnoCare Announces Approval of Clinical Trial of Novel SHP2 Allosteric Inhibitor ICP-189 in China

BEIJING, Oct. 19, 2021 /PRNewswire/ -- InnoCare Pharma (HKEX: 09969) announced today that the Company has received Investigational New Drug (IND) approval from the NMPA for itsSHP2 (Src Homology 2 domain containing protein tyrosine phosphatase) allosteric inhibitor ICP-189, which is the company's...

2021-10-19 12:56 1746

The Journal of Medicinal Chemistry Publishes Study Showing Potential of the Potent EED Inhibitor EEDi-5273 (APG-5918) to Achieve Complete Tumor Regression by Modulating the Epigenetics

SUZHOU, China, and ROCKVILLE, Md., Oct. 18, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that a research team led by Prof. Shaomeng Wang, ...

2021-10-18 22:42 2813

Bigo Live Continues its Partnership with Living Beyond Breast Cancer(R) to Honor Breast Cancer Awareness Month

LOS ANGELES, Oct. 18, 2021 /PRNewswire/ -- Bigo Live , a global leader in live streaming, today announced it's made a$10,000 donation to Living Beyond Breast Cancer (LBBC). LBBC is a national nonprofit that provides people with trusted information and...

2021-10-18 21:00 1956

Roan Holdings Group Announces Agreement to Set Up Joint Venture to Acquire Multimedia Interactive Technologies and Expand into Culture and Tourism Industry Markets

BEIJING and HANGZHOU, China, Oct. 18, 2021 /PRNewswire/ -- Roan Holdings Group Co., Ltd. ("Roan" or the "Company") (OTC Pink: RAHGF and RONWF), a provider of diversified solutions in financial, insurance and healthcare related products and management services, today announced that the Company has...

2021-10-18 20:00 2375

Farmmi Healthcare Subsidiary Receives BRC and HACCP Certifications

LISHUI, China, Oct. 18, 2021 /PRNewswire/ -- Farmmi, Inc. ("Farmmi" or the "Company") (NASDAQ: FAMI) announced that one of its healthcare subsidiaries, Zhejiang Farmmi Biotechnology Co., Ltd., has been assessed and has been awarded the certificate for compliance with the requirements of BRC Glob...

2021-10-18 20:00 1665

I-Mab Announces IND Approval for Phase 2 Clinical Trial of Efineptakin Alfa in Combination with PD-1 Therapy in China

SHANGHAI and GAITHERSBURG, Md., Oct. 18, 2021 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, today announced that the Center for Drug Evaluation (CDE) of the China ...

2021-10-18 20:00 1573

Gryphon Investors Announces Acquisition of Metagenics

Investment Will Support Leading Global Nutritional Products Provider's Mission to Improve Health Outcomes in Partnership with Healthcare Practitioners SAN FRANCISCO, Oct. 18, 2021 /PRNewswire/ -- Gryphon Investors ("Gryphon"), a leading middle-market private equity firm, today announced that it ...

2021-10-18 19:00 1486

Concord Medical Is Shortlisted for the "5G+Healthcare" Pilot Project

BEIJING, Oct. 18, 2021 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializing in cancer care, research and prevention by operating a network of medically advanced comprehensive cancer hospitals and standalone ...

2021-10-18 16:08 1927

WuXi ATU Opens New Manufacturing Facility to Further Enhance Its CTDMO Services for Global Customers

PHILADELPHIA, Oct. 17, 2021 /PRNewswire/ -- WuXi Advanced Therapies Inc. (WuXi ATU) – a wholly owned subsidiary of WuXi AppTec – today announced the opening of its new process development and commercial manufacturing facility in Lin-gang, Shanghai. WuXi ATU is a leading Contract, Testing, Develop...

2021-10-18 11:05 1735

Concord Medical Files 2020 Annual Report on Form 20-F

BEIJING, Oct. 15, 2021 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM ), a healthcare provider specialized in c...

2021-10-16 06:00 3765

Neusoft Ranks Top in China Healthcare Security Informatization Market

SHENYANG, China, Oct. 15, 2021 /PRNewswire/ -- According to the Market Shares of Healthcare Security Information System ofChina 2020: Building a New Healthcare Security Information System recently released by International Data Corporation (IDC) for the first time, Neusoft Corporation ("Neusoft",...

2021-10-15 23:06 3067

CellOrigin secured a new round of investment for developing its globally proprietary iPSC-CAR-Macrophage technology platform

HANGZHOU, China, Oct. 15, 2021 /PRNewswire/ -- On Oct. 11th, 2021, CellOrigin Inc. released data about its second generation of iPSC-CAR-Macrophage which has a genetically integrated secondary signal to confer controlled CAR-iMac polarization, in the 5th International Conference of IGC China, 202...

2021-10-15 20:50 1506

Akeso is Rapidly Advancing The Phase II Clinical Trial of IL-4R Monoclonal Antibody (AK120) for the Treatment of Atopic Dermatitis and Asthma

HONG KONG, Oct. 15, 2021 /PRNewswire/ -- Akeso, Inc. (the Company, 9926.HK) announces that the Company's self-developed innovative drug candidate, IL-4R monoclonal antibody (AK120), was approved by the Center for Drug Evaluation (CDE) of the National Medical Products Administration ofthe People...

2021-10-15 12:44 1693

GV20 Oncotherapy Completes Series B Financing to Advance Pipeline into the Clinic and Expand Immuno-Oncology Drug Discovery Platform

SHANGHAI, Oct. 14, 2021 /PRNewswire/ -- GV20 Oncotherapy, a biotechnology company with unique expertise in novel target identification and antibody drug discovery in immuno-oncology, today announced the completion of its Series B financing. This round of financing was led by Coatue Management,...

2021-10-14 23:55 1617

GV20 Oncotherapy Completes Series B Financing to Advance Pipeline into the Clinic and Expand Immuno-Oncology Drug Discovery Platform

Posture360 Receives Venture Capital to Drive Growth in Healthcare Industry

NEW YORK, Oct. 14, 2021 /PRNewswire/ -- Posture360, an industry leader in smart wearable technologies, has received an investment from Legendary Ventures as it is set to launch PostureSense®, the next-generation Smart Shirt that tracks, monitors, and analyzes physical activities (with real-time b...

2021-10-14 21:00 1530

1 ... 197 198 199200201 202 203 ... 280